RESULTS	The average improvement in walking speed among dalfampridine-treated TWRs during the 8-week efficacy evaluation period was 24.7 % from baseline ( 95 % confidence interval , 21.0-28 .4 % ) ; the mean improvement at the last on-treatment visit was 25.7 % , showing maintenance of effect over the interdosing period .\